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This study is aimed to determine the characteristics of the trends in incidence of basal cell carcinoma (BCC) in the
Netherlands. We used incidence data of BCC from the Eindhoven Cancer Registry (Comprehensive Cancer Centre
South) in the south of the Netherlands from 1973 to 2000. Data were age-adjusted and age-specific rates were
calculated. Joinpoint and age-period-birth cohort modelling were applied. Between 1973 and 2000, age-adjusted
incidence rates of BCC increased in both sexes, most markedly among (young) females. Recent increases were
most marked on the trunk. The male data ﬁtted age-drift models, suggesting a linear increase in rates over time, not
attributable to either period- or cohort effects. In females, age-cohort-drift models described the data adequately,
suggesting changes in intermittent UV exposures in subsequent cohorts. Incidence of BCC in the Netherlands is
increasing rapidly, especially at body sites that are not chronically exposed to sunlight. The most likely explanation
is an increased intermittent overexposure to UV radiation. This could have introduced an equal fractional increase
in risk at all ages in all cohorts. There is no indication of an end to this trend in BCC.
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Over the last decades, increasing trends in the incidence of
basal cell carcinoma (BCC) have been observed for Cau-
casian populations, with a decreasing average age of onset
(Coebergh et al, 1991; Ko et al, 1994; Levi et al, 1995; Holme
et al, 2000). An analysis of the nature of trends in incidence
of BCC by age, period, and birth cohort in the Netherlands
can clarify to what extent the behaviors (sun-exposure-
related) are birth cohort related.
It has been estimated that more than one-third of all
cancers in the USA are NMSC (Preston and Stern, 1992),
and that in Australia, which has the highest rate of skin
cancer in the world, the estimated incidence in 1985 was
twice that for all other cancers combined (Giles et al, 1988).
Rates in Europe are generally lower, albeit unknown in most
areas: in the southeastern parts of the Netherlands BCC
accounted for 17% of all cancer cases in both males and
females (calculated from Coebergh et al, 2001).
We analyzed incidence rates for primary BCC in the
Southeast of the Netherlands in the periods 1973–2000, by
sex, site, and age. To determine trends, we further inves-
tigated variations by birth cohort and period.
Results
Overall incidence data Between 1973 and 2000, a total of
23,511 primary BCC cases were diagnosed in the Eindh-
oven Cancer Registry region (11,865 males and 11,646
females).
The age-specific incidence curves illustrate the high in-
cidence rates of BCC, even at relatively young ages (Fig 1).
Seventy-seven percent of all BCC material that was analy-
zed in the pathology lab was sent by dermatologists, 8% by
general surgeons, 8% by plastic surgeons, 3% by general
practitioners and 4% by other specialists.
Between 1973 and 2000, the age-adjusted incidence
rates for BCC (European Standard Population) increased
from 40 to 92 per 100,000 person-years for males and from
34 to 79 per 100,000 person-years for females, with an es-
timated annual percentage change (EAPC) of 2.4% for
males and 3.9% for females (Table I, Fig 2). In the period
1973–2000, cumulative incidence risk before the age of 75
increased from 3.1% to 7.3% in males and from 2.5% to
6.2% in females. Age-specific incidence rose amongst all
age groups in both sexes, especially in young women
(EAPC 5.7%) (Table I, Fig S1 available online). Rates in
young females became higher, and increased more rapidly
than in young males; rates in the middle-aged (50–69) were
about equal for both sexes, but in older males incidence
remained higher than in females.
Incidence by site BCC occurred predominantly in the
head and neck region in both sexes, followed by the trunk
and the limbs, with higher rates on the limbs for females
than for males. Increases in rates were seen at all sites, with
smallest increases in the head and neck region, and most
notable increases on the trunk and in females (Table I,
Fig S2 available online).
Abbreviations: APC, age period cohort; BCC, basal cell carcinoma;
EAPC, estimated annual percentage change; ESR, European
standardized rate
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The proportion of BCC in the head and neck region de-
creased over time for both sexes, especially in the younger
age group, whereas the proportion on the trunk, arms, and
legs increased significantly in this age group. The strongest
proportional increases were seen on the trunk in young
males and females (Table S1 available online).
Joinpoint analyses No changes in the linear trends were
observed in the joinpoint analyses (results not shown), im-
plying that no changes in the linear trend, such as signs of
levelling off or sudden increases in rates, were detected.
Figure 1
Age-specific incidence curve for basal cell carcinoma (100,000
person-years), solid line, males; dashed line, females.
Figure2
Incidence of basal cell carcinoma, 3 year moving average, Euro-
pean standardized rates (ESR) (100,000 person-years). Solid line,
males; dashed line, females.
Table I. Overall, age- and site-specific incidence of basal cell carcinoma (per 105 person-years) by sex, 1973–2000
Males Females
EAPCa (95% CI) Incidenceb EAPCa (95% CI) Incidenceb
All ages 2.4 (2.2–2.5) 93 3.9 (3.7–4.1) 82
25–49 2.2 (1.9–2.4) 33 5.7 (5.4–6.0) 45
50–69 2.4 (2.3–2.6) 204 4.5 (4.4–4.6) 191
70þ 2.4 (2.3–2.4) 522 2.2 (2.2–2.3) 340
Head/neck 1.7 (1.6–1.8) 71 2.9 (2.8–3.1) 57
Trunk 5.7 (5.4–6.0) 15.4 7.7 (7.4–8.1) 15.7
Arms 4.6 (4.1–5.1) 5.5 7.7 (7.1–8.3) 6.0
Legs 6.9 (6.1–7.7) 3.8 7.9 (7.3–8.5) 4.6
Other and overlapping 0.91 (0.91–0.95) 0.2 0.97 (0.96–0.98) 0.4
aEstimated annual percentage change with 95% confidence interval (CI).
bIncidence: Age-standardised incidence rates per 100,000 person-years for the period 1998–2000.
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Age-period-cohort analysis of incidence data Age-peri-
od-cohort analyses resulted in an age-drift model that was
the most parsimonious model for males, while an age-drift-
cohort model fitted the data adequately for females (Table
S2 available online). Relative risks in females decreased
from the earliest birth cohorts, born in the beginning of the
20th century, until those cohorts born in 1921, then levelled
off and started increasing again, up until the most recent
birth cohorts (Fig 3).
Discussion
BCC is the most common malignant tumor in persons with a
pale skin in the Netherlands. Even though its incidence rates
are currently already very high, increases in incidence of
several percents per year are observed. There are no indi-
cations of flattening or recession of this trend, in contrast
with incidence rates of cutaneous melanomas, which are
flattening off in the young age groups in the Netherlands,
like in other Northern European countries (de Vries et al,
2003a, b). Increases in BCC were most rapid in young fe-
males, in whom incidence rates are currently higher than in
males, especially on the trunk and limbs (Bastiaens et al,
1998).
In other parts of Europe, reported (world standardized)
incidence rates of BCC per 100,000 person-years varied
markedly (Table II). It must be noted, however, that some of
these observations were made about a decade ago, and if
rates had increased in the same speed as in the Nether-
lands, the incidence rates would currently be substantially
higher.
Trend analyses of incidence are of course sensitive to
changes in the detection by increased awareness of pa-
tients and the availability of medical attention. Due to a
higher awareness amongst health care professionals and
the general population, detection and registration rates may
have improved. We observed, however, different changes
by age group, subsite, and sex, which would be evidence
against artifactual rises of the rates.
Moreover, this registry-based study in the southeastern
part of the Netherlands may have been hampered by the
usual difficulties, such as incomplete registration and inad-
equate histological verification, especially if BCC would be
excised by general pracitioners. There are several reasons,
however, why we believe that the vast majority of BCC are
reported to the cancer registry, and the registration of pri-
mary BCC is very good: our good contacts with dermatol-
ogists and pathologists which are supported by the
nationwide computerized PALGA archive, and the fact that
most general practitioners do not excise (suspected) BCC
(in our study about 3%) (Eulderink, 1994). Moreover, in the
cases where general practitioners excise the BCC, the pa-
thologists receive the specimens for examination and the
BCC will be reported to the cancer registry.
Table II. Reported age standardized incidence rates (world standard population, per 100,000 person-years) and increases
in rates in Western Europe
Registry Year Males Females Increase
Finland (Hannuksela-Svahn et al, 1999) 1991–1995 49 45 240% (1966/1970 vs 1991/1995)
Hull, UK 1991 116a 104a 335% (1978/1991)
(Ko et al, 1994)
Vaud, Switzerland 1991–1992 69 62 144% (males 1976/1980 vs 1991/1992)
(Levi et al, 1995) 182% (females 1976/1980 vs 1991/1992)
Wales 1998 128 105 15% (1988/1998)
(Holme et al, 2000)
Schleswig-Holstein. Germany 1998–2001 54 44 
(Katalinic et al, 2003)
Eindhoven, the Netherlands 1998–2000 63 58 185% (males 1973/1975 vs 1998–2000)
286% (females 1973/1975 vs 1998–2000)
aCrude rate.
Figure 3
Cohort effects in females from age-cohort-drift model. Relative
risk by birth cohort (reference cohort: 1946).
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Ultraviolet radiation is the most important environmental
risk factor for the development of BCC, especially in those
with a sun-sensitive skin type, although the mechanism is
still unclear. A particular amount of sun exposure delivered
in infrequent, probably intense ‘‘bursts’’ may increase the
risk of BCC more than a similar dose delivered evenly
spread over the same total period of time (Kricker et al,
1995a, b). This hypothesis matches with our data. BCC in-
creasingly appear on sites, mainly the trunk, that are not
continuously exposed to the sun when outdoors.
The increased incidence rates are most likely caused by
changes in sunbathing behavior in the young and middle-
aged, which has changed markedly during the twentieth
century. Especially, after the Second World War, more lei-
sure time became available for outdoor activities and for
holidays in the sun, wherebye since the 1980s holidays to
the (sub) tropics became affordable for many. Clothes
changed allowing larger parts of the skin to be exposed,
especially on the beaches. These changes were strongest
in young females, and resulted in increasing exposure of the
usually covered body sites (trunk, arms, legs) to ultraviolet
radiation.
Traditionally, BCC were more commonly seen in
older patients, usually males, and presented on the chron-
ically exposed skin, such as the head and neck area. Based
on our results, we expect that the ‘‘typical’’ BCC patients in
northwestern Europe are becoming younger, more often
female, and increasingly with affected sites other than the
head and neck area, i.e., more commonly the trunk.
BCC incidence rates in women exhibited a cohort-effect,
with still increasing rates in younger birth cohorts, which im-
plies a behavioral risk factor, probably sun exposure, with an
increasing influence over successive generations. As this ef-
fect is not discernable in the trend in men, it appears that the
trend in men is mainly attributable to ‘‘drift’’, possibly caused
by intermittent overexposure to solar UV radiation, which in-
creased more gradually over time in a broad age range.
The two most important histological subtypes of BCC are
nodular and superficial BCC, possibly with different etio-
logical mechanisms. Superficial BCC occurs in younger
patients, more often in females than in males, and on the
trunk and extremities. Nodular BCC occurs significantly
more often in males and in the head and neck region. Su-
perficial BCC (on the trunk) appear to be related to inter-
mittent sun exposure, whereas the nodular BCC (on the
face and neck) appear to be related more to chronic sun
exposure (Bastiaens et al, 1998). Based on our observations
of an increase in BCC, most marked in young females,
mainly on the trunk and extremities, with a decrease in the
proportion of BCC in the head and neck region, especially in
the young and middle-aged, we hypothesize that the in-
creases have been mainly in superficial BCC. An increase
in intermittent (mostly recreational) sun exposure and de-
crease in chronic (mostly occupational) sun exposure is
likely as well. The proportional increase of nodular BCC
observed in a university-hospital-based study in the west-
ern part of the country with time, and in all body regions,
does not contradict the above, because there may have
been specific referral of these patients to the university
hospital where the study was conducted (Bastiaens et al,
1998).
In conclusion, the most likely explanation for the increas-
ing incidence rate of BCC, especially at body sites that are
not chronically exposed to sunlight is increased intermittent
overexposure to UV radiation. This could have introduced
an equal fractional increase in risk at all ages in all cohorts.
In contrast to trends in melanoma incidence, there is no
indication of an end to this trend in BCC.
Materials and Methods
Data Data on incident primary BCC cases, according to anatom-
ical site, were obtained from the population-based Eindhoven
Cancer Registry (Coebergh et al, 2001). The Eindhoven cancer
registry serves more than 12 general hospitals that are served by
six pathologic laboratories, all participating in the nationwide PAL-
GA network, which also notifies the regional cancer registries. The
cancer registry receives lists of newly diagnosed cases on a reg-
ular basis from the pathology departments, including cases whose
material was sent in by general practitioners. In addition, the med-
ical records departments of the hospitals provide lists of outpa-
tients and hospitalized cancer patients. Following this notification,
the medical records of newly diagnosed patients (and tumors), of-
ten only available from the outpatient departments, are collected
and trained tumor registrars from the cancer registry abstract the
necessary information. Data are checked for duplicate records.
Records are assumed to be complete. Only first primary BCC were
registered.
During the study period 1973–2000, the population size of the
Eindhoven cancer registry catchment region increased from
592,000 to 2,100,000, mainly due to an expansion of the registry
area (Coebergh et al, 2001).
Annual incidence rates were computed per 100,000 person-
years for each sex and calculated as 3-y moving means.
Analysis Age adjustment was performed by direct standardiza-
tion according to the European Standard Population (European
standardized rates (ESR)). Cumulative incidence rates were
calculated as the sum of the age-specific incidence rates for
ages 0–74, multiplied with the width of the age groups (5 y).
Cumulative risks were calculated from the cumulative rates as
follows:
Cumulative risk¼ 100  (1exp (cumulative rate/100)).
Trends in incidence were estimated by calculating the esti-
mated annual percentage change (EAPC) using STATA 7 software
(STATA Corporation, College Station, Texas). The EAPC was cal-
culated by fitting a regression line to the natural logarithm of the
rates using calendar year as a regressor variable, i.e., y¼mxþb
where y¼ ln(rate) and x¼ calendar year. Then the EAPC¼ 100 
(em 1). This calculation assumes that the rates increased or
decreased at a constant rate over the entire period.
Joinpoint analyses were performed to discern significant
changes in the trend and, if present, when they occurred (Kim
et al, 2000). Linear line segments are connected on a log scale to
identify changes in trend data in terms of the annual rates of
change in fixed periods of time (Kim et al, 2000), although cross-
sectional cancer rates generally do not change abruptly. The soft-
ware used for these analyses was the Joinpoint Regression Pro-
gram, version 2.6 of the National Cancer Institute.
Age, drift, period, and birth cohort effects were investigated
using the age-period-cohort modelling as described by Clayton
and Schifflers, using STATA 7 software (Clayton and Schifflers,
1987). ‘‘Drift’’ is a term, which was introduced by Clayton and
Schifflers to describe models for which age-period and age-cohort
parameters fit the data equally well. The model implies the same
linear change in the logarithm of the rates over time in each age
group. Such a model thus serves as an estimate of the rate of
change of a regular trend (Clayton and Schifflers, 1987). Included
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age groups were those between 25 and 74 y of age. Five-year
periods were chosen from 1976–1980 until 1996–2000.
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The following material is available from http://www.blackwellpublish-
ing.com / products / journals/suppmat / JID / JID23306 / JID23306sm.htm
Figure S1. Age-specific incidence rates (105 person-years) for basal
cell carcinoma, according to sex, 3 y moving average.
Figure S2. Site-specific incidence of basal cell carcinoma, according to
sex, 3 y moving average, with EAPC (head, head and neck; trunk, trunk;
arm, arms and shoulders; leg, legs and hips; other, other cutaneous and
not speciﬁed).
Table S1. Body site distribution of basal cell carcinoma by period,
age, and sex.
Table S2. Goodness-of-ﬁt statistics of the age-period-cohort anal-
ysis (25–74 year old)
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